Why has the Opioid Crisis Remained Unchanged in Canada? The Limits of Bio-Scientific Based Policy Approaches

References

• Adelson, N. (2005, March-April). The embodiment of inequity: Health disparities in Aboriginal Canada. Canadian Journal of Public Health, 96(Suppl 2), S45–61. https://doi.org/10.1007/BF03403702
   PubMed Web of Science ®Google Scholar
• Barry, C. A. (2006). The role of evidence in alternative medicine: Contrasting biomedical and anthropological approaches. Social Science & Medicine, 62(11), 2646–2657. https://doi.org/10.1016/j.socscimed.2005.11.025
   PubMed Web of Science ®Google Scholar
• Bell, J., & Strang, J. (2020). Medication treatment of opioid use disorder. Biological Psychiatry, 87(1), 82–88. https://doi.org/10.1016/j.biopsych.2019.06.020
   PubMed Web of Science ®Google Scholar
• Belzak, L., & Halverson, J. (2018). The opioid crisis in Canada: A national perspective”. Research, Policy and Practice, 38(6), 224–233.
   Google Scholar
• Belzak, L., & Halverson, J. (2018). The overdose death crisis in Canada: A national perspective. Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice, 38(6), 224–233. https://doi.org/10.24095/hpcdp.38.6.02
   PubMed Web of Science ®Google Scholar
• Bruneau, J., Ahamad, K., Goyer, M.-E., Poulin, G., Selby, P., Fischer, B., Wild, C., & Wood, E. (2018). On behalf of the CIHR Canadian research initiative in substance misuse. Canadian Medical Association Journal, 190(9), E247–E257. https://doi.org/10.1503/cmaj.170958
   PubMed Web of Science ®Google Scholar
• Bueckert, K. (2019, June 10). May marks busiest month ever for opioid overdose calls to paramedics in Waterloo region. CBC News.
   Google Scholar
• Canadian Association of Social Workers. (2020). What is social work. https://www.casw-acts.ca/en/what-social-work
   Google Scholar
• Carroll, J. J., Marshall, B. D., Rich, J. D., & Green, T. C. (2017). Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study. International Journal of Drug Policy, 46, 136–145. https://doi.org/10.1016/j.drugpo.2017.05.023
   PubMed Web of Science ®Google Scholar
• Clarke, S. F., Dargan, P. I., & Jones, A. L. (2005). Naloxone in opioid poisoning: Walking the tightrope. Emergency Medicine Journal, 22(9), 612–616. https://doi.org/10.1136/emj.2003.009613
   PubMed Web of Science ®Google Scholar
• Crowe, K. (2018, June 2). New questions about old Canadian study foreshadowing opioid crisis. CBC News.
   Google Scholar
• Csiernik, R. (2021). Substance use and misuse: Everything matters, third edition. Canadian Scholars Press.
   Google Scholar
• Csiernik, R., & Rowe, W. (2017). Creating a holistic understanding of addiction. In R. Csiernik & W. S. Rowe (Eds.), Responding to the oppression of addiction: Canadian social work perspectives (3rd ed., pp. 7–26). Canadian Scholars Press.
   Google Scholar
• Daly, J. (2005). Evidence-based medicine and the search for a science of clinical care. University of California Press.
   Google Scholar
• Dean, K. (2004). The role of methods in maintaining orthodox beliefs in health research. Social Science and Medicine, 58(4), 675–685. https://doi.org/10.1016/S0277-9536(03)00219-3
   PubMed Web of Science ®Google Scholar
• Dell, C., Roberts, G., Kilty, J., Taylor, K., Daschuk, M., Hopkins, C., & Dell, D. (2012). Researching prescription drug misuse among First Nations in Canada: Starting from a health promotion framework. Substance Abuse: Research and Treatment, 6, 23–31. https://doi.org/10.4137/SART.S9247
   PubMedGoogle Scholar
• Dorman, K., Biedermann, B., Linklater, C., & Jaffer, Z. (2018). Community strengths in addressing opioid use in Northeastern Ontario. Canadian Journal of Public Health, 109(2), 219–222. https://doi.org/10.17269/s41997-018-0055-4
   PubMed Web of Science ®Google Scholar
• Drug Policy Alliance. (2019). Drug decriminalization in Portugal: Learning from a health and human-centred approach (pp. 1–12). https://drugpolicy.org/sites/default/files/dpa-drug-decriminalization-portugal-health-human-centered-approach_0.pdf
   Google Scholar
• Dunham, J. (2017, February 23). ’Wake-up call’ as Ottawa community grapples with drug overdoses. CTV News.
   Google Scholar
• Dunham, J. (2019, April 10)Vol. 10,p. 000 opioid-related deaths recorded in Canada from 2016 to 2018. CTV News.
   Google Scholar
• Dyck, D. (2018, July 24). Ontario to review safe injection, overdose prevention sites, health minister says. The Canadian Press. https://www.cbc.ca/news/canada/toronto/ontario-safe-injection-sites-limbo-1.4760002
   Google Scholar
• Eren, K., Schuster, J., Herschell, A., Loveland, D., Neimark, G., Mihalyo, M., Hurford, M., Houck, P., & Ryan, N. (2021). Association of counseling and psychotherapy on retention in medication for addiction treatment within a large medicaid population. Journal of Addiction Medicine, Publish Ahead of Print. https://doi.org/10.1097/adm.0000000000000914
   Web of Science ®Google Scholar
• Farmer, P., Nizeye, B., Stulac, S., & Keshavjee, S. (2019). Structural violence and clinical medicine. In P. Brown and S. Glosser (Eds.), Foundations of global health: An interdisciplinary reader (Vol. 34, pp. 324–333). Oxford University Press.
   Google Scholar
• Felix, S., Portugal, P., & Tavares, A. (2017). Going after the addiction, not the addicted: The impact of drug decriminalization in Portugal. In Discussion paper series (pp. 1–28). IZA – Institute of Labor Economics.
   Google Scholar
• Fischer, B., Peng, M., & Tyndall, M. (2019). The opioid death crisis in Canada: Lessons for public health. The Lancet Public Health, 4(2), E81–E82. https://doi.org/10.1016/S2468-2667(18)30232-9
   PubMed Web of Science ®Google Scholar
• Fischer, B., Rehm, J., & Tyndall, M. (2016). Effective Canadian policy to reduce harms from prescription opioids: Learning from past failures. Canadian Medical Association Journal, 188(17–18), 1240–1244. https://doi.org/10.1503/cmaj.160356
   PubMed Web of Science ®Google Scholar
• Government of Canada. (2016). Pillars of the Canadian drugs and substances strategy. https://www.canada.ca/en/health-canada/services/publications/healthy-living/pillars-canadian-drugs-substances-strategy.html
   Google Scholar
• Government of Canada. (2018). Government of Canada actions on opioids: 2016 and 2017. https://www.canada.ca/en/health-canada/services/publications/healthy-living/actions-opioids-2016-2017.html
   Google Scholar
• Government of Canada. (2019). Evidence base: Canadian drugs and substances strategy. https://www.canada.ca/en/health-canada/services/substance-use/canadian-drugs-substances-strategy/evidence.html
   Google Scholar
• Government of Canada. (2021). Opioid- and stimulant related harms in Canada (March 2021). https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/
   Google Scholar
• Government of Canada, Department of Justice. (2018). Evaluation of the national anti-drug strategy. https://www.justice.gc.ca/eng/rp-pr/cp-pm/eval/rep-rap/2018/nads-sna/eilp-epji.html”
   Google Scholar
• Griffiths, N. (2021, October 22). Opioid deaths in B.C. far outpaced those from COVID-19. Vancouver Sun.
   Google Scholar
• Hedrich, D., & Hartnoll, R. L. (2021). Harm-reduction interventions. In M. El-guebaly, G. Carra, M. Galanter, & A. Baldacchino (Eds.), Textbook of addiction treatment (pp. 757–775). Springer.
   Google Scholar
• Helmerhorst, G. T. T., Teunis, T., Janssen, S. J., & Ring, D. (2017). An epidemic of the use, misuse and overdose of opioids and deaths due to overdose, in the United States and Canada: Is Europe next? The Bone & Joint Journal, 99(7), 856–864. https://doi.org/10.1302/0301-620X.99B7.BJJ-2016-1350.R1
   PubMedGoogle Scholar
• Hernandez, J. (2019, April 16). ‘He was so broken’: BC mother loses son to opioids after years of sobriety. CBC News.
   Google Scholar
• Hollenberg, D., & Muzzin, I. (2010). Epistemological challenges to integrative medicine. An anti-colonial perspective on the combination of complementary/alternative medicine with biomedicine. Health Sociology Review, 19(1), 34–56. https://doi.org/10.5172/hesr.2010.19.1.034
   Web of Science ®Google Scholar
• Hyshka, E., Anderson-Baron, J., Karekezi, K., Belle-Isle, L., Elliott, R., Pauly, B., Strike, C., Asbridge, M., Dell, C., McBride, K., Hathaway, A., & Wild, T. C. (2017). Harm reduction in name, but not substance: A comparative analysis of current Canadian provincial and territorial policy frameworks. Harm Reduction Journal, 14(50). https://doi.org/10.1186/s12954-017-0177-7
   PubMedGoogle Scholar
• Johansson, J., Hirvonen, J., Lovró, Z., Ekblad, L., Kaasinen, V., Rajasilta, O., Helin, S., Tuisku, J., Siren, S., Pennanen, M., Agrawal, A., Crystal, R., Vainio, P., Alho, H., & Scheinin, M. (2019). Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects. Neuropsychopharmacology, 44(9), 1667–1673. https://doi.org/10.1038/s41386-019-0368-x
   PubMed Web of Science ®Google Scholar
• Jongbloed, K., Pearce, M., Pooyak, S., Zamar, D., Thomas, V., Demerais, L., Christian, W., Henderson, E., Sharma, R., Blair, A., Yoshida, E., Schechter, M. & Spittal. P. (2017, November 6). The cedar project: Mortality among young indigenous people who use drugs in British Columbia. Canadian Medical Association Journal, 189(44), E135 9. https://doi.org/10.1503/cmaj.160778.
   Web of Science ®Google Scholar
• Jozaghi, E., Nizeye, B., Stulac, S. & Keshavjee, S. (2018). Activism and scientific research: 20 years of community action by the Vancouver area network of drug users. Substance Abuse Treatment, Prevention and Policy, 13(18). https://doi.org/10.1186/s13011-018-0158-1
   PubMedGoogle Scholar
• Jozaghi, E., Lumpkin, H., & Andresen, M. (2016). Peer engagement and its role in reducing risky behaviour among crack and methamphetamine smokers of the downtown eastside community of Vancouver, Canada. Harm Reduction Journal, 13(1), 19. https://doi.org/10.1186/s12954-016-0108-z
   PubMedGoogle Scholar
• Jozaghi, E., & Yake, K. (2020). Two decades of activism: Social justice, and public health civil disobedience: VANDU. Canadian Journal of Public Health, 111(1), 143–144. https://doi.org/10.17269/s41997-019-00287-0
   PubMed Web of Science ®Google Scholar
• Kerr, T., Mitra, S., Kennedy, M. C., & McNeil, R. (2017). Supervised injection facilities in Canada: Past, present, and future. Harm Reduction Journal, 14(1), 1–9. https://doi.org/10.1186/s12954-017-0154-1
   PubMedGoogle Scholar
• Labelle, B., Franklyn, A. M., PKH Nguyen, V., Anderson, K. E., Eibl, J. K., & Marsh, D. C. (2018). Characterizing the use of telepsychiatry for patients with opioid use disorder and co-occurring mental health disorders in Ontario, Canada. International Journal of Telemedicine and Applications, 2018, 1–7. https://doi.org/10.1155/2018/7937610
   Google Scholar
• Laquer, H. (2015). Uses and abuses of drug decriminalization in Portugal. Law & Social Inquiry, 40(3), 746–781. https://doi.org/10.1111/lsi.12104
   Web of Science ®Google Scholar
• Lavalley, J., Kastor, S., Valleriani, J., & McNeil, R. (2018, December 17). Reconciliation and Canada’s overdose crisis: Responding to the needs of Indigenous peoples”. Canadian Medical Association Journal, 190(50), E1466–7. https://doi.org/10.1503/cmaj.181093
   Web of Science ®Google Scholar
• Lötsch, J. (2005). Pharmacokinetic–pharmacodynamic modeling of opioids. Journal of Pain and Symptom Management, 29(5), 90–103. https://doi.org/10.1016/j.jpainsymman.2005.01.012
   Web of Science ®Google Scholar
• Manhapra, A., Agbese, E., Leslie, D. L., & Rosenheck, R. A. (2018). Three-year retention in buprenorphine treatment for opioid use disorder among privately insured adults. Psychiatric Services (Washington, D.C.), 69(7), 768–776. HYPERLINK ““. https://doi.org/10.1176/appi.ps.201700363
   PubMed Web of Science ®Google Scholar
• Marsh, T., Coholic, D., Cote-Meek, S., & Najavits, L. M. (2015, May 20). Blending Aboriginal and Western healing methods to treat intergenerational trauma with substance use disorder in Aboriginal peoples who live in northeastern Ontario, Canada. Harm Reduction Journal, 12(1), 14. https://doi.org/10.1186/s12954-015-0046-1
   PubMed Web of Science ®Google Scholar
• Meyer, B., Utter, G. L., & Hillman, C. (2021). A personalized, interactive, cognitive behavioral therapy–based digital therapeutic (MODIA) for adjunctive treatment of opioid use disorder: Development study. JMIR Mental Health, 8(10), e31173. https://doi.org/10.2196/31173
   PubMed Web of Science ®Google Scholar
• Ning, A. (2013). How ‘alternative’ is CAM? Rethinking conventional dichotomies between biomedicine and complementary/alternative medicine. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 17(2), 135–158. https://doi.org/10.1177/1363459312447252
   Google Scholar
• Ning, A. (2018). Epistemic hybridity: TCM’s knowledge production in Canadian contexts. In C. Brosnan, P. Vuolanto, & J.-A. Darnell (Eds.), Complementary and alternative medicine: Knowledge production and social transformation (Vol. 10, pp. 247–272). Palgrave MacMillan, Science, Technology and Society Series.
   Google Scholar
• Perkel, C. (2019, March 29). Ontario announces 15 overdose prevention sites across province. The Canadian Press.
   Google Scholar
• Sasitharan, K. (2021, December 7). Toronto board of health votes to decriminalize possession of small amounts of illegal drugs. CBC News.
   Google Scholar
• Scher, B. (2020). Biopower, disciplinary power and surveillance: A qualitative analysis of the lived experience of drug users in Vancouver’s downtown eastside. [M.A. thesis in public issues anthropology]. UWSpace. http://hdl.handle.net/10012/15726
   Google Scholar
• Slade, H. (2021). Drug decriminalization in Portugal: Setting the record straight. TRANSFORM Drug Policy Foundation, 1–10. https://transformdrugs.org/assets/files/PDFs/Drug-decriminalisation-in-Portugal-setting-the-record-straight.pdf
   Google Scholar
• Srivastava, A., Kahan, M., & Nader, M. (2017). Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone? Canadian Family Physician Medecin de Famille Canadien, 63(3), 200–205. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349718/
   PubMed Web of Science ®Google Scholar
• Tompkins, P. (2018). Confronting the disparity in nonmedical prescription opioid use among rural and urban youth: A call for broader recognition in the era of clandestine fentanyl. UBC Medical Journal, 9(2), 36–37. https://ojs.library.ubc.ca/index.php/ubcmj/article/view/190000
   Google Scholar
• Vander Laenen, F. (2011). How drug policy should (not) be: Institutionalised young people’s perspectives”. International Journal of Drug Policy, 22(6), 491–497. https://doi.org/10.1016/j.drugpo.2011.10.005
   PubMed Web of Science ®Google Scholar
• Vashishtha, D., Mittal, M. L., & Werb, D. (2017). The North American opioid epidemic: Current challenges and a call for treatment as prevention. Harm Reduction Journal, 14(1), 1–6. https://doi.org/10.1186/s12954-017-0135-4
   PubMedGoogle Scholar
• Villanueva-Russell, Y. (2005). Evidence-based medicine and its implications for the profession of chiropractic. Social Science and Medicine, 60(3), 545–561. https://doi.org/10.1016/j.socscimed.2004.05.017
   PubMed Web of Science ®Google Scholar
• Watson, T. M., Kolla, G., van der Meulen, E., & Dodd, Z. (2020). Critical studies of harm reduction: Overdose response in uncertain political times. International Journal of Drug Policy, 76, 102615. https://doi.org/10.1016/j.drugpo.2019.102615
   PubMed Web of Science ®Google Scholar
• Webster, F., Rice, K., & Abhimanyu, S. (2020). A critical content analysis of media reporting on opioids: The social construction of an epidemic. Social Science and Medicine, 244, 1126–1142. https://doi.org/10.1016/j.socscimed.2019.112642
   Web of Science ®Google Scholar